New Treatment Option for ER+/HER2

April 14, 2015 – Pfizer is sponsoring a program discussing a new treatment option for ER+/HER2 – metastatic breast cancer. This program will also be at Opus at 6:00pm. RSVPs can be registered at www.pfizerrsvphcp.com.



No comments have been posted yet.